Citations Report

Citation Index - Clinical Investigation [920 Articles]

The articles published in Clinical Investigation have been cited 920 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Clinical Investigation.

  • Wilbers RH (2015) Plant biotechnology meets immunology: plant-based expression of immunologically relevant proteins. Wageningen University.

    View at Publisher | View at Google Scholar
  • Nam HJ, Kwon JY, Choi HY, Kang SH, Jung HS et al. (2016) Production and Purification of Recombinant Glucocerebrosidase in Transgenic Rice Cell Suspension Cultures. Applied Biochemistry and Biotechnology 5:1-5.

    View at Publisher | View at Google Scholar
  • Weaver KN, Grabowski GA, Burrow TA (2015) Velaglucerase alfa in the treatment of Gaucher disease type 1: an update. Clinical Investigation 5(6):543-9.

    View at Publisher | View at Google Scholar
  • Michaud JP, Modi R, Phillips MI. Is orphan drug pricing blowing a bubble? The unique situation of orphan drugs and why high prices will likely persist.

    View at Publisher | View at Google Scholar
  • Wagner ES. Purificação da enzima glucocerebrosidase humana produzida no leite do primeiro clone caprino transgênico da América Latina (Master's thesis, Pontifícia Universidade Católica do Rio Grande do Sul).

    View at Publisher | View at Google Scholar
  • Geraldo RB, Sathler PC, Lourenço AL, Saito MS, Cabral LM, et al. (2014) Platelets: still a therapeutical target for haemostatic disorders. International journal of molecular sciences 15(10):17901-19.

    View at Publisher | View at Google Scholar
  • Geraldo RB, Sathler PC, Lourenço AL, Saito MS, Cabral LM, et al. (2014) Platelets: still a therapeutical target for haemostatic disorders. International journal of molecular sciences 15(10):17901-19.

    View at Publisher | View at Google Scholar
  • 王如菊, 许佩佩, 欧阳建. 生物药物载体在肿瘤治疗中的研究进展. 东南大学学报: 医学版. 2015(4):623-8.

    View at Publisher | View at Google Scholar
  • Iorio A, Marcucci M, Makris M (2011) Concentrate‐related inhibitor risk: is a difference always real? Journal of Thrombosis and Haemostasis 9(11):2176-9.

    View at Publisher | View at Google Scholar
  • Ribeiro L, Bandello F, Tejerina AN, Vujosevic S, Varano M, et al. (2015) Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2Identification of Retinopathy in Diabetic Patients. Investigative ophthalmology & visual science 56(9):5698-705.

    View at Publisher | View at Google Scholar
  • Cunha-Vaz J, Zrenner E. GEUDER AG.

    View at Publisher | View at Google Scholar
  • Cunha-Vaz J, Zrenner E. GEUDER AG.

    View at Publisher | View at Google Scholar
  • CARE ET. GEUDER AG.

    View at Publisher | View at Google Scholar
  • Soares ML CARACTERIZAÇÃO DAS FASES INICIAIS DA RETINOPATIA DIABÉTICA. DIAGNÓSTICO PRECOCE E BIOMARCADORES DA ATIVIDADE DA RETINOPATIA DIABÉTICA (Doctoral dissertation, Universidade de Coimbra).

    View at Publisher | View at Google Scholar
  • Benakova N (2011) Phototherapy of psoriasis in the era of biologics: still in. Acta Dermatovenerologica Croatica 19(3).

    View at Publisher | View at Google Scholar
  • Li K, Huang CC, Randazzo B, Li S, Szapary P, et al. (2016) HLA-C* 06: 02 allele and response to IL-12/23 inhibition: results from the ustekinumab phase 3 psoriasis program. Journal of Investigative Dermatology 136(12):2364-71.

    View at Publisher | View at Google Scholar
  • Sardana N, Craig TJ (2011) Recent advances in management and treatment of hereditary angioedema. Pediatrics 128(6):1173-80.

    View at Publisher | View at Google Scholar
  • Auberger J, Lass-Flörl C, Aigner M, Clausen J, Gastl G, et al. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. Journal of Antimicrobial Chemotherapy 67(9):2268-73.

    View at Publisher | View at Google Scholar
  • Tuite NL, Lacey K (2013) Overview of invasive fungal infections. Fungal Diagnostics: Methods and Protocols :1-23.

    View at Publisher | View at Google Scholar
  • Auberger J, Greil R, Lass-Flörl C (2012) What paths are open for tackling increasing azole resistance in Aspergillus in the clinic? Expert review of anti-infective therapy 10(11):1229-31.

    View at Publisher | View at Google Scholar
  • Auberger J, Russ G, Greil R, Egle A (2011) Treatment of invasive aspergillosis in cancer patients. memo-Magazine of European Medical Oncology 4(4):266-72.

    View at Publisher | View at Google Scholar
  • Ni M, Chen Y, Fei T, Li D, Lim E, et al. (2013) Amplitude modulation of androgen signaling by c-MYC. Genes & development 27: 734-748.

    View at Publisher | View at Google Scholar
  • Lawrance IC (2014) What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails? World Journal of Gastroenterology: WJG 20(5):1248.

    View at Publisher | View at Google Scholar
  • Ceva E, Moratti S (2013) Whose self-determination? Barriers to access to emergency hormonal contraception in Italy. Kennedy Institute of Ethics Journal 23(2):139-67.

    View at Publisher | View at Google Scholar
  • Magee M. Is Mitt Romney (Like George W. Bush) Going To Throw Science Under The Bus?

    View at Publisher | View at Google Scholar
  • MUCÁRZEL SUÁREZ ARANA JO, ARANCIBIA ULLOA FL (2013) Pildora del dia despues 1. Universidad, Ciencia y Sociedad. Sep:53.

    View at Publisher | View at Google Scholar
  • Grenham S, Clarke G, Cryan JF, Dinan TG (2011) Brain–gut–microbe communication in health and disease. Frontiers in physiology 2:94

    View at Publisher | View at Google Scholar
  • Lacombe D, Bean J, Bogaerts J, Bottomley A, Collette L, et al. (2012) 50 years of the EORTC and the central role of the EORTC Headquarters. European Journal of Cancer Supplements10:3-12

    View at Publisher | View at Google Scholar
  • Kataoka K, Nakamura K, Caballero C, Evrard S, Negrouk A, et al. (2016) Collaboration between EORTC and JCOG—how to accelerate global clinical research partnership. Japanese Journal of Clinical Oncology

    View at Publisher | View at Google Scholar
  • Hourigan CS, Karp JE (2013) Minimal residual disease in acute myeloid leukaemia. Nature reviews Clinical oncology10:460-71

    View at Publisher | View at Google Scholar
  • Ramos NR, Mo CC, Karp JE, Hourigan CS (2015) Current approaches in the treatment of relapsed and refractory acute myeloid leukemia. Journal of clinical medicine4:665-95

    View at Publisher | View at Google Scholar
  • Kitson SL, Quinn DJ, Moody TS, Speed D, Watters W, et al. (2013) Antibody-Drug Conjugates (ADCs)–Biotherapeutic bullets. Chim Oggi-Chem Today31:30-6

    View at Publisher | View at Google Scholar
  • Hourigan CS, Karp JE (2013) Personalized therapy for acute myeloid leukemia. Cancer discovery3:1336-8

    View at Publisher | View at Google Scholar
  • Khan M, Mansoor AE, Kadia TM (2016) Future prospects of therapeutic clinical trials in acute myeloid leukemia. Future Oncology

    View at Publisher | View at Google Scholar
  • Wang R (2017) Current Standards and New Treatment Insights in HER2-Driven Metastatic Breast Disease. American Journal of Hematology/Oncology®12

    View at Publisher | View at Google Scholar
  • Decker B, Parker HG, Dhawan D, Kwon EM, Karlins E, et al. (2015) Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer—Evidence for a relevant model system and urine-based diagnostic test. Molecular Cancer Research13:993-1002

    View at Publisher | View at Google Scholar
  • Leow JJ, Orsola A, Chang SL, Bellmunt J (2015) A contemporary review of management and prognostic factors of upper tract urothelial carcinoma. Cancer treatment reviews41:310-9

    View at Publisher | View at Google Scholar
  • Elyamany A, Aboziada M, Abbas H (2013) Management of bladder cancer: A literature review. International Research Journal of Medicine and Medical Sciences1:13-26

    View at Publisher | View at Google Scholar
  • Gabril MY, Yousef GM (2014) Molecular Testing in Urothelial Tumors. In: Molecular Testing in Cancer. Springer New York

    View at Publisher | View at Google Scholar
  • Goldenberg MM (2012) Multiple sclerosis review. PT37:175-84

    View at Publisher | View at Google Scholar
  • Liu KK, Sakya SM, O’Donnell CJ, Flick AC, Ding HX (2012) Synthetic approaches to the 2010 new drugs. Bioorganic & medicinal chemistry20:1155-74

    View at Publisher | View at Google Scholar
  • 周丽萍, 孙黎, 叶海伟 (2015) 维纳卡兰类似物的合成及活性研究. 精细化工中间体45:31-5

    View at Publisher | View at Google Scholar
  • 叶海伟, 俞传明, 钟为慧, 苏为科 (2014) (1R, 2R)-2-((R)-3-(苄氧基) 吡咯烷基) 环己醇的合成研究. 高校化学工程学报28:606-11

    View at Publisher | View at Google Scholar
  • 叶海伟, 陈云华, 周丽萍, 俞传明 (2014) 维纳卡兰的合成研究进展. 有机化学34:1759-65

    View at Publisher | View at Google Scholar
  • Hartmann M (2014) Clinical cancer research in transition. In: Forum 29: 485-492

    View at Publisher | View at Google Scholar
  • Metzger-Filho O, De Azambuja E, Bradbury I, Saini KS, Bines J, et al. (2013) Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience. The oncologist18:134-40

    View at Publisher | View at Google Scholar
  • Piccart-Gebhart MJ (2013) The 41st David A Karnofsky memorial award lecture: academic research worldwide—quo vadis?. Journal of Clinical Oncology32:347-54

    View at Publisher | View at Google Scholar
  • Michalsen BT, Gherezghiher TB, Choi J, Chandrasena RE, Qin Z, et al. (2012) Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol. Chemical research in toxicology25:1472-83

    View at Publisher | View at Google Scholar
  • Mak L, Liggi S, Tan L, Kusonmano K, M Rollinger J, et al. (2013) Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism. Current pharmaceutical design19:532-77

    View at Publisher | View at Google Scholar
  • Gilbert MR (2011) Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches In: Seminars in oncology . WB Saunders View at Publisher | View at Google Scholar

Relevant Topics